Publication | Closed Access

Hormonal Therapy Plus Bevacizumab in Postmenopausal Patients Who Have Hormone Receptor–Positive Metastatic Breast Cancer: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

Breast OncologyPhase Ii TrialMedicineGynecologyBreast CancerMenopausePharmacotherapyOncologyRadiation OncologyPostmenopausal PatientsEndocrine-related CancerMenopause Hormone Therapy